| Primary |
| Drug Use For Unknown Indication |
46.2% |
| Hypertension |
13.5% |
| Ischaemic Cardiomyopathy |
7.7% |
| Pre-eclampsia |
7.7% |
| Prophylaxis |
3.8% |
| Aphthous Stomatitis |
1.9% |
| Convulsion |
1.9% |
| Diabetes Mellitus Non-insulin-dependent |
1.9% |
| Epilepsy |
1.9% |
| Ischaemia |
1.9% |
| Pain |
1.9% |
| Prophylaxis Against Transplant Rejection |
1.9% |
| Pulmonary Oedema |
1.9% |
| Stress |
1.9% |
| Threatened Labour |
1.9% |
| Tocolysis |
1.9% |
|
| Acute Pulmonary Oedema |
5.0% |
| Cutaneous Vasculitis |
5.0% |
| Drug Exposure During Pregnancy |
5.0% |
| Foetal Arrhythmia |
5.0% |
| Hepatocellular Injury |
5.0% |
| Hypoxic-ischaemic Encephalopathy |
5.0% |
| Lung Disorder |
5.0% |
| Lymphangitis |
5.0% |
| Malaise |
5.0% |
| Pneumothorax |
5.0% |
| Premature Baby |
5.0% |
| Premature Labour |
5.0% |
| Proteinuria |
5.0% |
| Rhabdomyolysis |
5.0% |
| Skin Exfoliation |
5.0% |
| Skin Necrosis |
5.0% |
| Thrombocytopenic Purpura |
5.0% |
| Tinnitus |
5.0% |
| Toxic Skin Eruption |
5.0% |
| Tubulointerstitial Nephritis |
5.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
32.5% |
| Product Used For Unknown Indication |
20.7% |
| Hypertension |
15.4% |
| Back Pain |
3.3% |
| Depression |
3.0% |
| Prophylaxis |
2.9% |
| Type 2 Diabetes Mellitus |
2.8% |
| Dyslipidaemia |
1.9% |
| Epidural Anaesthesia |
1.7% |
| Tocolysis |
1.7% |
| Lymphoma |
1.6% |
| Drug Exposure During Pregnancy |
1.5% |
| Epilepsy |
1.5% |
| Neuropsychiatric Lupus |
1.5% |
| Pre-eclampsia |
1.5% |
| Atrial Fibrillation |
1.3% |
| Parkinson's Disease |
1.3% |
| Constipation |
1.2% |
| Insomnia |
1.2% |
| Pain |
1.2% |
|
| Fall |
10.5% |
| Thrombocytopenia |
9.5% |
| Somnolence |
8.4% |
| Transaminases Increased |
7.4% |
| Hepatocellular Injury |
6.3% |
| Stroke Volume Decreased |
6.3% |
| Cytolytic Hepatitis |
5.3% |
| Neuropathy Peripheral |
5.3% |
| Jaundice |
4.2% |
| Renal Failure |
4.2% |
| Toxic Epidermal Necrolysis |
4.2% |
| Agranulocytosis |
3.2% |
| Convulsion |
3.2% |
| Dyspnoea |
3.2% |
| Erythema Multiforme |
3.2% |
| Intra-uterine Death |
3.2% |
| Lactic Acidosis |
3.2% |
| Malaise |
3.2% |
| Overdose |
3.2% |
| Pancreatic Carcinoma Metastatic |
3.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
23.9% |
| Hypertension |
21.9% |
| Drug Use For Unknown Indication |
20.1% |
| Hiv Infection |
3.3% |
| Ischaemic Cardiomyopathy |
3.1% |
| Prophylaxis |
3.1% |
| Pain |
3.0% |
| Myocardial Ischaemia |
2.2% |
| Depression |
2.2% |
| Diabetes Mellitus |
2.2% |
| Hypercholesterolaemia |
2.0% |
| Multiple Myeloma |
1.9% |
| Thrombosis Prophylaxis |
1.9% |
| Neuralgia |
1.6% |
| Hypothyroidism |
1.4% |
| Non-small Cell Lung Cancer |
1.4% |
| Type 2 Diabetes Mellitus |
1.4% |
| Atrial Fibrillation |
1.3% |
| Myocardial Infarction |
1.2% |
| Antiviral Treatment |
1.2% |
|
| Renal Failure Acute |
10.0% |
| Thrombocytopenia |
9.6% |
| Renal Failure |
9.2% |
| Somnolence |
8.3% |
| Vomiting |
7.9% |
| Pyrexia |
4.8% |
| Sepsis |
4.8% |
| Hyponatraemia |
4.4% |
| Pancreatitis Acute |
4.4% |
| Urinary Tract Infection |
4.4% |
| General Physical Health Deterioration |
3.9% |
| Eosinophilia |
3.5% |
| Toxic Skin Eruption |
3.5% |
| Hepatocellular Injury |
3.1% |
| Hyperkalaemia |
3.1% |
| Myocardial Infarction |
3.1% |
| Neutropenia |
3.1% |
| Persecutory Delusion |
3.1% |
| Rash Maculo-papular |
3.1% |
| Rectal Haemorrhage |
3.1% |
|
| Interacting |
| Hypertension |
50.0% |
| General Anaesthesia |
20.0% |
| Anaesthesia |
10.0% |
| Induction Of Anaesthesia |
10.0% |
| Neuralgia |
10.0% |
|
| Drug Interaction |
33.3% |
| Left Ventricular Failure |
33.3% |
| Suicidal Ideation |
33.3% |
|
